InVitae is led by a team of experienced professionals (listed in alphabetical order):
Lisa Alderson
Lisa has extensive marketing experience building technology, media and consumer Internet businesses. She founded her first company at the age of 19 and has now been involved with seven early-stage ventures, of which two have gone public, two were acquired and two are still privately held. Lisa is also an active angel investor, founding partner, board member and advisor with a track record of creating, funding and managing high-growth ventures. She was a former Manager of Strategic Planning at The Walt Disney Company and has an MBA from Harvard Business School.
Michele Cargill
Michele has more than a decade of experience as a human geneticist in both industry and academia, with a primary interest in discovering the genes that contribute to human disease and applying that knowledge into developing risk models of disease and translating that information for patients and medical care professionals. She trained under the tutelage of David Botstein at Stanford Medical School, where she earned her PhD in genetics, and Eric Lander at the Whitehead Institute, where she did her postdoctoral training. Prior to co-founding Locus, Dr. Cargill was VP of Genetics at Navigenics and Associate Director of Genomic Collaborations at Affymetrix. She also served as Senior Staff Scientist at Celera Diagnostics and Scientific Program Manager at Celera Genomics.
Sean George
Sean George was co-founder and CEO of Locus Development, an early stage genetic analysis startup. Prior to co-founding Locus, he served as COO at Navigenics, an early leader in personalized medicine. Previously, he has also served as SVP of Marketing and SVP, Life Science Business at Affymetrix as well as VP, Labeling and Detection Business at Invitrogen. In the past, he has also worked at McKinsey & Co. and Molecular Probes. Dr. George holds a BS in Molecular Genetics from UCLA, an MS in Molecular Biology from UC Santa Barbara, and a PhD in Molecular Genetics from UC Santa Cruz.
Jill Hagenkord
Dr. Hagenkord is a board-certified pathologist and molecular genetic pathologist. Prior to joining InVitae, Jill served as Chief Medical Officer and Senior Vice President at Complete Genomics, Inc. Her other prior experiences include founder and Chief Medical Officer for iKaryos Diagnostics, Associate Professor of Pathology at Creighton University School of Medicine, Director of Molecular Pathology and Clinical Genomics at Creighton Medical Laboratories, and pathologist at Deltagen, Inc. Dr. Hagenkord received her MD from Stanford University School of Medicine in 1999, did her residency training in pathology at the University of California at San Francisco and the University of Iowa, and completed fellowships in Pathology/Oncology Informatics and Molecular Genetic Pathology at the University of Pittsburgh Medical Center.
Steve Lincoln
Steve was the Vice President of Scientific Applications at Complete Genomics, where he led the team responsible for the analysis of whole genome sequence data. Prior to Complete Genomics, he was Vice President of Informatics for Affymetrix, where he was responsible for software development, chip design, and data analysis functions. Prior to that he was CSO of the bioinformatics software company Informax (now part of Life Technologies, and makers of VectorNTI), and before that he was Vice President of Bioinformatics for Incyte and was one of the founding staff the MIT/Whitehead Center for Genome Research.
Randy Scott
Prior to co- founding InVitae, Randy served as Genomic Health’s Chief Executive Officer from 2000 until 2009 and Executive Chairman until 2012. Under Randy’s leadership, Genomic Health developed and launched two revolutionary cancer diagnostics tests. At Incyte, Randy served in various roles from 1991 through 2000, including Chairman of the Board, President and Chief Scientific Officer. Randy holds a Bachelor of Science degree in Chemistry from Emporia State University and a Ph.D. in Biochemistry from the University of Kansas. Randy is a prominent thought leader in the genomics and sequencing space and is the author of over 40 publications, 20 patents, and is the recipient of numerous awards which highlight his leadership in the personalized medicine space.
Rick Tompane
Rick joined Genomic Health during the incubation of InVitae and prior to co-founding InVitae, he was President and CEO of Gemfire, an integrated photonics company serving cloud computing and internet Optical System Integrators all over the world. He has a broad background with large and small companies, venture capital and start up experience, product manufacturing and intellectual property development, as well as an in-depth technical education in both Mechanical and Electrical Engineering with a Masters from Stanford University. Past experience includes being co-founder of The 3DO Company (partner to Electronics Arts), founder and CEO of Mirus Corporation (funded by Apple Computer and Polaroid), co-founder and Managing General Partner of Onset (a seed stage venture capital fund and joint venture with a product design firm now known as IDEO) and Product Line Marketing Manager for the original Macintosh at Apple Computer.